Literature DB >> 24484500

Vaccine-induced rabies in a red fox (Vulpes vulpes): isolation of vaccine virus in brain tissue and salivary glands.

Peter Hostnik1, Evelyne Picard-Meyer, Danijela Rihtarič, Ivan Toplak, Florence Cliquet.   

Abstract

Oral vaccination campaigns to eliminate fox rabies were initiated in Slovenia in 1995. In May 2012, a young fox (Vulpes vulpes) with typical rabies signs was captured. Its brain and salivary gland tissues were found to contain vaccine strain SAD B19. The Basic Logical Alignment Search Tool alignment of 589 nucleotides determined from the N gene of the virus isolated from the brain and salivary glands of the affected fox was 100% identical to the GenBank reference SAD B19 strain. Sequence analysis of the N and M genes (4,351 nucleotides) showed two nucleotide modifications at position 1335 (N gene) and 3114 (M gene) in the KC522613 isolate identified in the fox compared to SAD B19.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24484500     DOI: 10.7589/2013-07-183

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  12 in total

1.  A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein.

Authors:  Caiquan Zhao; Jie Gao; Yongzhi Wang; Lina Ji; Hui Qin; Wei Hu; Yang Yang
Journal:  Front Microbiol       Date:  2022-06-08       Impact factor: 6.064

2.  A Century Spent Combating Rabies in Morocco (1911-2015): How Much Longer?

Authors:  Sami Darkaoui; Florence Cliquet; Marine Wasniewski; Emmanuelle Robardet; Nadia Aboulfidaa; Mohammed Bouslikhane; Ouafaa Fassi-Fihri
Journal:  Front Vet Sci       Date:  2017-06-02

3.  Control and elimination of rabies in Croatia.

Authors:  Tomislav Bedeković; Ivana Lohman Janković; Ivana Šimić; Nina Krešić; Ivana Lojkić; Ivica Sučec; Emmanuelle Robardet; Florence Cliquet
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

4.  Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.

Authors:  Jennifer R Head; Ad Vos; Jesse Blanton; Thomas Müller; Richard Chipman; Emily G Pieracci; Julie Cleaton; Ryan Wallace
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

5.  Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.

Authors:  Conrad M Freuling; Verena Te Kamp; Antonia Klein; Maria Günther; Luca Zaeck; Madlin Potratz; Elisa Eggerbauer; Katharina Bobe; Christian Kaiser; Antje Kretzschmar; Steffen Ortmann; Peter Schuster; Adriaan Vos; Stefan Finke; Thomas Müller
Journal:  Viruses       Date:  2019-08-27       Impact factor: 5.048

6.  Spatio-temporal Use of Oral Rabies Vaccines in Fox Rabies Elimination Programmes in Europe.

Authors:  Thomas F Müller; Ronald Schröder; Patrick Wysocki; Thomas C Mettenleiter; Conrad M Freuling
Journal:  PLoS Negl Trop Dis       Date:  2015-08-17

Review 7.  Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review.

Authors:  Philippe Mähl; Florence Cliquet; Anne-Laure Guiot; Enel Niin; Emma Fournials; Nathalie Saint-Jean; Michel Aubert; Charles E Rupprecht; Sylvie Gueguen
Journal:  Vet Res       Date:  2014-08-10       Impact factor: 3.683

Review 8.  Rabies in the Baltic States: Decoding a Process of Control and Elimination.

Authors:  Emmanuelle Robardet; Evelyne Picard-Meyer; Marianna Dobroštana; Ingrida Jaceviciene; Katrin Mähar; Zita Muižniece; Gediminas Pridotkas; Marius Masiulis; Enel Niin; Edvīns Olševskis; Florence Cliquet
Journal:  PLoS Negl Trop Dis       Date:  2016-02-05

Review 9.  Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms.

Authors:  A El-Sayed
Journal:  Int J Vet Sci Med       Date:  2018-05-18

10.  Population- and Variant-Based Genome Analyses of Viruses from Vaccine-Derived Rabies Cases Demonstrate Product Specific Clusters and Unique Patterns.

Authors:  Sten Calvelage; Marcin Smreczak; Anna Orłowska; Conrad Martin Freuling; Thomas Müller; Christine Fehlner-Gardiner; Susan Nadin-Davis; Dirk Höper; Paweł Trębas
Journal:  Viruses       Date:  2020-01-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.